These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16832680)

  • 1. Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study.
    Spargias K; Adreanides E; Giamouzis G; Karagiannis S; Gouziouta A; Manginas A; Voudris V; Pavlides G; Cokkinos DV
    Eur J Clin Pharmacol; 2006 Aug; 62(8):589-95. PubMed ID: 16832680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Adreanides E; Demerouti E; Gkouziouta A; Manginas A; Pavlides G; Voudris V; Cokkinos DV
    Circulation; 2009 Nov; 120(18):1793-9. PubMed ID: 19841299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
    Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
    JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of the Use of Iloprost, A Synthetic Prostacyclin, in the Prevention of Radiocontrast Nephropathy in Patients Undergoing Coronary Angiography and Intervention.
    Kassis HM; Minsinger KD; McCullough PA; Block CA; Sidhu MS; Brown JR
    Clin Cardiol; 2015 Aug; 38(8):492-8. PubMed ID: 25963191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
    Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME; Oraby MA; Ismail HM; Maklady FA
    J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
    Huber W; Schipek C; Ilgmann K; Page M; Hennig M; Wacker A; Schweigart U; Lutilsky L; Valina C; Seyfarth M; Schömig A; Classen M
    Am J Cardiol; 2003 May; 91(10):1157-62. PubMed ID: 12745095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
    Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
    Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiocontrast nephropathy: is it dose related or not?
    Mekan SF; Rabbani MA; Azhar-uddin M; Ali SS
    J Pak Med Assoc; 2004 Jul; 54(7):372-4. PubMed ID: 15449920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
    Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
    Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
    Tumlin JA; Wang A; Murray PT; Mathur VS
    Am Heart J; 2002 May; 143(5):894-903. PubMed ID: 12040355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: a multicenter prospective randomized study.
    Koc F; Ozdemir K; Altunkas F; Celik A; Dogdu O; Karayakali M; Gul EE; Erkorkmaz U; Kadi H; Akpek M; Kaya MG
    J Investig Med; 2013 Jun; 61(5):872-7. PubMed ID: 23552179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial.
    Habib M; Hillis A; Hammad A
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):55-61. PubMed ID: 26787567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of acetylcysteine in prevention of contrast nephropathy.
    Azmus AD; Gottschall C; Manica A; Manica J; Duro K; Frey M; Bulcão L; Lima C
    J Invasive Cardiol; 2005 Feb; 17(2):80-4. PubMed ID: 15687530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nebivolol in the prevention of contrast-induced nephropathy in patients with renal dysfunction.
    Avci E; Yeşil M; Bayata S; Postaci N; Arikan E; Cirit M
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):613-7. PubMed ID: 21959875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
    J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.